1. Home
  2. LRN vs DYN Comparison

LRN vs DYN Comparison

Compare LRN & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stride Inc.

LRN

Stride Inc.

N/A

Current Price

$75.19

Market Cap

3.5B

Sector

Real Estate

ML Signal

N/A

DYN

Dyne Therapeutics Inc.

N/A

Current Price

$15.53

Market Cap

2.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LRN
DYN
Founded
2000
1984
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Medicinal Chemicals and Botanical Products
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.5B
2.8B
IPO Year
2007
2020

Fundamental Metrics

Financial Performance
Metric
LRN
DYN
Price
$75.19
$15.53
Analyst Decision
Hold
Strong Buy
Analyst Count
3
17
Target Price
★ $102.50
$34.33
AVG Volume (30 Days)
850.7K
★ 2.2M
Earning Date
10-20-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 20.00
N/A
EPS
★ 1.45
N/A
Revenue
★ $917,734,000.00
N/A
Revenue This Year
$2.10
N/A
Revenue Next Year
$4.63
N/A
P/E Ratio
$52.55
★ N/A
Revenue Growth
★ 3.29
N/A
52 Week Low
$60.61
$14.00
52 Week High
$103.67
$27.31

Technical Indicators

Market Signals
Indicator
LRN
DYN
Relative Strength Index (RSI) 41.56 38.49
Support Level $73.87 $14.43
Resistance Level $84.08 $19.48
Average True Range (ATR) 2.54 0.96
MACD 0.03 -0.21
Stochastic Oscillator 22.51 0.56

Price Performance

Historical Comparison
LRN
DYN

About LRN Stride Inc.

Stride Inc is a technology company providing an educational platform to deliver proprietary and third-party curriculum, software systems, and educational services designed to facilitate individualized learning for students and adults throughout the U.S. The platform delivers products and services to attract, enroll, educate, track progress, and support students. It provides customized solutions to public and private schools, school districts, charter boards, employers, government agencies, and consumers. Its platform addresses two markets in the K-12 space: General Education and Career Learning, with products and services for the General Education market predominantly focused on core subjects for kindergarten through twelfth grade students.

About DYN Dyne Therapeutics Inc.

Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease being treated, a linker, and an antigen-binding fragment that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.

Share on Social Networks: